F. Shen

发表

Genome-Wide Association Study for Anthracycline-Induced Congestive Heart Failure.

Lang Li, G. Sledge, I. Gradus-Pizlo, 2016, Clinical cancer research : an official journal of the American Association for Cancer Research.

Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial.

J. Gregg, C. Savran, C. Isaacs, 2020, JAMA oncology.

Passage number affects differentiation of sensory neurons from human induced pluripotent stem cells

Guanglong Jiang, B. Schneider, Xi Wu, 2022, Scientific Reports.

Discerning the clinical relevance of biomarkers in early stage breast cancer

M. Smith, Guanglong Jiang, B. Schneider, 2017, Breast Cancer Research and Treatment.

A non-coding GWAS variant impacts anthracycline-induced cardiotoxic phenotypes in human iPSC-derived cardiomyocytes

Guanglong Jiang, B. Schneider, Xi Wu, 2022, Nature Communications.

Transcriptome-wide association study uncovers the role of essential genes in anthracycline-induced cardiotoxicity

B. Carleton, B. Schneider, Amit P. Bhavsar, 2021, npj Genomic Medicine.

Transcriptome-wide association study uncovers the role of essential genes in anthracycline-induced cardiotoxicity

B. Carleton, B. Schneider, Amit P. Bhavsar, 2021, NPJ genomic medicine.

The impact of SBF2 on taxane-induced peripheral neuropathy

Guanglong Jiang, B. Schneider, J. Wan, 2022, PLoS genetics.

Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients

K. Owzar, M. Ratain, M. Bertagnolli, 2021, British Journal of Cancer.

Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients

K. Owzar, M. Ratain, M. Bertagnolli, 2021, British Journal of Cancer.

Impact of Genetic Ancestry on Outcomes in ECOG-ACRIN-E5103.

Lang Li, G. Sledge, T. Foroud, 2017, JCO precision oncology.

BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer

J. Gregg, C. Isaacs, S. Badve, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Charcot-Marie-Tooth gene, SBF2, associated with taxane-induced peripheral neuropathy in African Americans

Lang Li, G. Sledge, T. Foroud, 2016, Oncotarget.

Pharmacogenetic biomarkers for the prediction of response to antiangiogenic treatment.

B. Schneider, K. Miller, F. Shen, 2012, The Lancet. Oncology.

Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.

Lauren L. Ritterhouse, E. Winer, C. Hudis, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Urgent hypertension as a biomarker for bevacizumab in the curative setting.

G. Sledge, D. Cameron, T. Suter, 2018 .

Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199

Daniel L. Koller, Lang Li, G. Sledge, 2015, Clinical Cancer Research.

Analytical Validation of Variants to Aid in Genotype-Guided Therapy for Oncology.

T. Skaar, B. Schneider, F. Shen, 2019, The Journal of molecular diagnostics : JMD.

Abstract GS5-02: Detection of circulating tumor DNA (ctDNA) after neoadjuvant chemotherapy is significantly associated with disease recurrence in early-stage triple-negative breast cancer (TNBC): Preplanned correlative results from clinical trial BRE12-158

J. Gregg, C. Isaacs, S. Badve, 2020 .

Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100

Daniel L. Koller, R. Gray, Lang Li, 2014, British Journal of Cancer.

Pilot trial of paclitaxel-trastuzumab adjuvant therapy for early stage breast cancer: a trial of the ECOG-ACRIN cancer research group (E2198)

G. Sledge, A. Thor, N. Davidson, 2015, British Journal of Cancer.

Prognostic and Predictive Value of Tumor Vascular Endothelial Growth Factor Gene Amplification in Metastatic Breast Cancer Treated with Paclitaxel with and without Bevacizumab; Results from ECOG 2100 Trial

R. Gray, E. Perez, Lang Li, 2013, Clinical Cancer Research.

Impact of African ancestry on the relationship between body mass index and survival in an early‐stage breast cancer trial (ECOG‐ACRIN E5103)

G. Sledge, Guanglong Jiang, B. Schneider, 2022, Cancer.

Identification of a Genomic Region between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance)

K. Owzar, M. Ratain, P. Friedman, 2018, Clinical Cancer Research.

Title Identification of a Genomic Region between SLC 29 A 1 and HSP 90 AB 1 Associated with Risk of Bevacizumab-Induced Hypertension : CALGB 80405 ( Alliance )

K. Owzar, M. Ratain, P. Friedman, 2018 .

Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more than 1,000 patients

K. Owzar, M. Ratain, M. Bertagnolli, 2020 .

Cytochrome P450 oxidoreductase, POR, associated with severe paclitaxel-induced peripheral neuropathy in patients of European ancestry from ECOG-ACRIN E5103.

G. Sledge, D. Northfelt, Guanglong Jiang, 2023, Clinical Cancer Research.

Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199

Daniel L. Koller, Lang Li, G. Sledge, 2015, Clinical Cancer Research.

Optimization of a human induced pluripotent stem cell-derived sensory neuron model for the in vitro evaluation of taxane-induced neurotoxicity

F. Shen, E. Cantor, Guanglong Jiang, 2024, Scientific reports.